JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ELLIS, S.
Right arrow Articles by STRAUS, O. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ELLIS, S.
Right arrow Articles by STRAUS, O. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 79, Issue 4, 295-308, 1943
Copyright © 1943 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES II. THE DESTRUCTION OF PHYSOSTIGMINE IN BUFFERED SOLUTIONS AND IN SERUM

SYDNEY ELLIS 1, FRANK L. PLACHTE 1, and OLIVER H. STRAUS 1

1 From the Department of Pharmacology, Harvard Medical School, Boston

1. A method is reported for the quantitative estimation of physostigmine at concentrations between 10–6 and 10–8 molar. This method depends upon the quantitative relation of the inhibition of serum cholinesterase activity to the physostigmine concentration in the above range of inhibitor concentration.

2. A colorimetric method for the estimation of physostigmine is described.

3. The decomposition of physostigmine in buffered solutions at pH 5-9 has been studied. The rate of destruction is a reflection of the physostigmine and hydroxyl ion concentrations.

4. The rate of serum inactivation of physostigmine has been shown to be related to the concentration of both the drug and the cholinesterase activity when the serum activity is greater than 15-20% of the normal uninhibited activity. When the physostigmine concentration is sufficient to depress the cholinesterase activity more completely, the rate of physostigmine destruction is slow. This is interpreted as an inhibition due to excess substrate (physostigmine).

Submitted on August 4, 1943







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1943 by the American Society for Pharmacology and Experimental Therapeutics.